Skip to main
IVVD
IVVD logo

Invivyd Inc (IVVD) Stock Forecast & Price Target

Invivyd Inc (IVVD) Analyst Ratings

Based on 3 analyst ratings
Strong Buy
Strong Buy 67%
Buy 33%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Invivyd Inc. recently bolstered its financial position by closing a public offering that raised $57.5 million, providing essential funding for its ongoing clinical programs. The company’s Phase 1/2 ‘extreme-dose’ safety trials have instilled high confidence in the long-term efficacy of its antibody candidates, particularly in providing robust protection against evolving viral threats. Additionally, the anticipated REVOLUTION launch is viewed as a significant milestone, reinforcing both regulatory and commercial prospects for Invivyd's innovative solutions in infectious disease management.

Bears say

Invivyd Inc. has experienced downward adjustments to its market share expectations, particularly regarding PEMGARDA in immunocompromised patient segments, leading to reduced price targets from $3.00 to $1.00 largely due to capital raise dilution. The company's reliance on the premise of enhanced, engineered immunity faces skepticism, particularly as it attempts to address concerns over current vaccine limitations such as waning antibody responses and public hesitancy. Additionally, the projected $4 billion revenue from COVID vaccine sales in 2024 highlights a competitive landscape, which may limit Invivyd's ability to capture significant market share amid doubts surrounding its product candidates.

Invivyd Inc (IVVD) has been analyzed by 3 analysts, with a consensus rating of Strong Buy. 67% of analysts recommend a Strong Buy, 33% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Invivyd Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Invivyd Inc (IVVD) Forecast

Analysts have given Invivyd Inc (IVVD) a Strong Buy based on their latest research and market trends.

According to 3 analysts, Invivyd Inc (IVVD) has a Strong Buy consensus rating as of Nov 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $7.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $7.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Invivyd Inc (IVVD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.